|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
Citrus bioflavonoids to witness increased demand from pharmaceutical applications
|
|
Tuesday, 16 February, 2021, 14 : 00 PM [IST]
|
|
Deepak Bandal
|
Cardiovascular diseases (CVDs) have emerged to be the leading cause of death globally, claiming an estimated 17.9 million lives almost every year of which, about 6 lakh 55 thousand people die from heart disease in the United States alone.
Such daunting numbers pertaining to rising CVDs have evoked the need for consumption of citrus bioflavonoids, in turn expanding the growth profile of the overall citrus bioflavonoids market over the span of 2020 to 2026. Citrus bioflavonoids are compounds generally found in citrus fruits like oranges, tangerines, and grapefruit. These come in handy to improve the blood flow and ease swelling in the body.
Rising intake of bioflavonoids helps in preventing free radicals from doing harm to the human body. In fact, the anti-inflammatory and antioxidant benefits of these compounds have been proven to support circulatory, metabolic, joint, and cognitive health. Moreover, they also support balanced immune cell activity for enhancing the immune response and respiratory health.
The versatility of citrus bioflavonoids makes them an ideal addition in food and beverage, and dietary supplement applications. These compounds can be suspended in liquids and might be used in various beverages and offer sour and bitter taste notes for specialty beverages, including beer. Besides, they also serve as natural preservatives, offering another benefit for food and beverage products.
Considering its umpteen benefits, citrus bioflavonoids are also being abundantly used in dietary supplements. A pivotal example of the same would be Meticore. The product, Meticore, is an innovative metabolism boosting support formula that serves as an all-natural appetite control supplement for body fat management, given the rising burden of obesity worldwide. As per numerous reports, citrus bioflavonoids in Meticore, are anticipated to offer a lean figure, which is achieved by burning calories, suppressing the genes associated with obesity, and prohibiting the accumulation of fat.
Will citrus bioflavonoids be helpful in managing hypertension?
Approximately 1.13 billion people worldwide suffer from hypertension, with about two-thirds living in low- and middle-income economies. In fact, hypertension has emerged as a major cause of premature death worldwide. Given the aforementioned statistics, it would be safe to say that the consumption of citrus fruits like oranges, tangerines, and others would add to a significant reduction in hypertension levels to a much larger extent.
It has been well established that a glassful of orange juice, enriched with potassium, natural citrus bioflavonoids, and folates, is known to support the metabolism and heart health, further keeping the person healthy and fit, both physically and mentally. On top of that, orange juice is considered to be one of the best sources of vitamin C and a freshly extracted juice offers about 100 per cent of the daily vitamin requirement, thus reducing the blood pressure significantly while helping in managing hypertension.
Elaborating further on combating the challenges of hypertension, obesity, diabetes, and other chronic illnesses, various companies have been looking toward the possibility of developing new bioflavonoids owing to their intrinsic health benefits and massive demand. In one such instance, Ingredients by Nature, a collaborative company operating in the field of production and commercialization of citrus flavonoids and yucca for human health, had in 2019 put forth the discovery of a new flavonoid complex to help regulate blood sugar levels, blood pressure, and inflammation.
Branded as Eriomin, the complex is deemed to be the first in an all new range of Erio products that build on the efficiency of eriocitrin in combination with other bioactives. Eriomin is constituted of citrus flavonoids like hesperidin, naringin, and eriocitrin, and aims at minimizing the pre-diabetes and inflammation to a greater extent. According to a report by CDC, pre-diabetes affects 1 in every 3 Americans, which would mean that need for controlling blood sugar levels is higher in the region.
On that note, it would be safe to declare that citrus bioflavonoids industry is expected to expand profusely in the economies of North America over the foreseeable time period, while also allowing the overall industry to record a remuneration of USD 1.3 billion by 2026 end.
(The author is senior SEO Executive, Global Market Insights, Inc.)
|
|
|
|
|
|
|
|
|
|